Adonis Tesamorelin 10mg – Research Pepitde (RUO)
£49.99 inc. VAT
In stock
Tesamorelin 10mg – Research Peptide
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) that has been studied for its interaction with endocrine signalling pathways involved in growth hormone regulation and downstream metabolic activity. In laboratory settings, Tesamorelin is commonly examined for its role in pituitary signalling and mechanisms associated with growth hormone pulsatility.
Scientific interest in Tesamorelin centres on how GHRH analogue peptides may influence regulatory communication between the hypothalamic-pituitary axis and peripheral metabolic systems under controlled research conditions.
Product Information
| Product Name | Tesamorelin |
| Content | 10mg Lyophilized Peptide |
| Form | Freeze-dried powder |
| Purity | >98% (HPLC Tested) |
| Storage | Store at −20°C (long-term recommended) |
| Stability | Stable under laboratory storage conditions |
| Application | Scientific and laboratory research use only |
Overview
Tesamorelin is widely studied in experimental models involving growth hormone-releasing hormone activity, endocrine feedback mechanisms, and metabolic signalling. As a modified GHRH analogue, it is often used in research exploring how upstream peptide regulators influence growth hormone release patterns and related biological pathways.
Laboratory investigations commonly examine Tesamorelin within models of hormonal signalling, cellular metabolism, and pituitary function, providing insight into the coordination between peptide messengers and systemic regulatory processes.
Potential Research Applications
- Growth hormone-releasing hormone pathway research
- Pituitary signalling and endocrine regulation studies
- Hormonal feedback mechanism investigations
- Metabolic signalling and energy balance models
- IGF-related downstream pathway research
- Experimental studies involving peptide-mediated endocrine communication
Scientific Background
Tesamorelin is a synthetic analogue based on growth hormone-releasing hormone, a peptide responsible for stimulating signalling pathways linked to growth hormone secretion in controlled biological systems. Research into GHRH analogues helps scientists investigate how modified peptides may affect receptor interaction, signalling duration, and downstream endocrine activity.
Experimental studies involving Tesamorelin frequently focus on the hypothalamic-pituitary axis, where peptide-based communication plays a critical role in coordinating hormonal output and metabolic balance. These models are useful for examining how specific peptide structures interact with receptor systems and influence broader signalling cascades.
Ongoing scientific work continues to explore how Tesamorelin contributes to understanding peptide-driven endocrine regulation, metabolic communication, and growth hormone-associated research pathways in controlled laboratory environments.
Safety and Handling
This compound is supplied strictly for laboratory research purposes. Handling should be performed by qualified personnel using appropriate laboratory safety procedures and controlled research conditions.
Use outside intended research applications is not recommended.
Disclaimer
Final NoteTesamorelin is supplied strictly for research use only.
|
| Weight | 10mg |
|---|---|
| Purity | Purity ≥98% (HPLC). COA available on request. Batch-tracked for traceability. |
| Compliance | RUO only. Not for human or veterinary use. No dosing or administration guidance provided. |
